Biocare Medical

Biocare Medical LLC is an innovator in automated immunohistochemistry (IHC) instrumentation, and the full range of reagents for IHC and in situ hybridization (ISH; RISH) testing. Biocare pioneered multiplex IHC detection which accelerates turnaround time, increases instrument productivity and reduces reagent consumption and cost by 50% or more.
Multiplex IHC allows pathologists to visualize more than one marker on a tissue at a time, allowing higher confidence for critical differentiation of NSCLC, breast, bladder and prostate cancer.
Biocare's intelliPATH FLX is the only completely open, continuous random access IHC instrument available.
The company’s customers come from clinical and research environments that do tissue based testing and include histology laboratories, pharmaceutical and biotechnology companies; CROs; and academic, government and military labs. Biocare Medical offers an expanding portfolio of products for the rapidly growing cancer and infectious disease diagnostic and research markets. Biocare medical is headquartered and has manufacturing facilities in Concord, Calif., and has a global distribution network. See biocare.net and slidestainer.com for more information.

NOTE: Biocare Medical, the Biocare Medical logo, and intelliPATH are trademarks of Biocare Medical LLC.

CONTACT: Biocare Medical, LLC
Mark Cross, 925-603-8014 (Media), Marketing Director
Biocare Medical 925-603-8000
4040 Pike Lane, Concord, CA 94520
http://www.biocare.net

Specialties

Cancer diagnostics; predictive tests for cancer; prognostic biomarkers; IHC (immunohistochemistry); ISH (in situ hybridization); molecular pathology tests; molecular oncology tests